Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced BiomedADVB +3.83%12 3-Year Book Growth Rate is -0.10% as of Mar. 2026. GuruFocus rates ADVB with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 192 Medical Diagnostics & Research companies, Advanced Biomed ranks better than 54.17% on this metric.
During the past 12 months, Advanced Biomed's average Book Value per Share Growth Rate was 109.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -0.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 5 years, the highest 3-Year average Book Value per Share Growth Rate of Advanced Biomed was 19.40% per year. The lowest was -0.10% per year. And the median was 9.65% per year.
Advanced Biomed (NAS:ADVB) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Advanced Biomed 3-Year Book Growth Rate Related Terms
ADVB vs BIOQ, QUCY, IDXG: 3-Year Book Growth Rate Comparison
For the Diagnostics & Research subindustry, Advanced Biomed's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Biomed 3-Year Book Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Advanced Biomed's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Advanced Biomed's 3-Year Book Growth Rate falls into.
Advanced Biomed 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of -0.10% mean?
Advanced Biomed (ADVB) has a 3-Year Book Growth Rate of -0.10% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Advanced Biomed and its competitors. According to the industry distribution chart, Advanced Biomed ranks #88 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 45.8%.
Is Advanced Biomed's 3-Year Book Growth Rate too high?
Advanced Biomed's current 3-Year Book Growth Rate is -0.10%. Based on the distribution chart, Advanced Biomed ranks #88 out of 192 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Advanced Biomed has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Advanced Biomed's 3-Year Book Growth Rate compare to BIOQ and QUCY?
According to the Medical Diagnostics & Research industry distribution chart, Advanced Biomed ranks #88 out of 192 companies for 3-Year Book Growth Rate. This puts Advanced Biomed in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Diagnostics & Research company?
A good 3-Year Book Growth Rate depends on the Medical Diagnostics & Research industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Advanced Biomed and its competitors. Advanced Biomed's current 3-Year Book Growth Rate is -0.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Biomed stock overvalued right now?
Advanced Biomed (ADVB) has a current 3-Year Book Growth Rate of -0.10%. The current 3-Year Book Growth Rate is -0.10%. Advanced Biomed's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Advanced Biomed (ADVB), the current 3-Year Book Growth Rate is -0.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
12GF Score
Get the complete analysis for ADVB
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADVB has been successfully added to your 
